| __timestamp | Blueprint Medicines Corporation | Zoetis Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 31844000 | 396000000 |
| Thursday, January 1, 2015 | 48588000 | 364000000 |
| Friday, January 1, 2016 | 81131000 | 376000000 |
| Sunday, January 1, 2017 | 144687000 | 382000000 |
| Monday, January 1, 2018 | 243621000 | 432000000 |
| Tuesday, January 1, 2019 | 331450000 | 457000000 |
| Wednesday, January 1, 2020 | 326860000 | 463000000 |
| Friday, January 1, 2021 | 601033000 | 508000000 |
| Saturday, January 1, 2022 | 477419000 | 539000000 |
| Sunday, January 1, 2023 | 427720000 | 614000000 |
| Monday, January 1, 2024 | 341433000 | 686000000 |
Unveiling the hidden dimensions of data
In the competitive landscape of pharmaceuticals, research and development (R&D) spending is a critical indicator of innovation and future growth. Over the past decade, Zoetis Inc. and Blueprint Medicines Corporation have demonstrated contrasting strategies in their R&D allocations.
From 2014 to 2023, Zoetis Inc., a leader in animal health, consistently invested in R&D, with expenditures peaking at approximately $614 million in 2023. This represents a steady increase of around 55% from their 2014 spending. Meanwhile, Blueprint Medicines Corporation, a pioneer in precision therapy, saw a dramatic rise in R&D spending, surging from about $32 million in 2014 to over $601 million in 2021, marking an impressive growth of nearly 1,780%.
These trends highlight the dynamic nature of R&D investments, reflecting each company's strategic priorities and commitment to innovation.
Research and Development: Comparing Key Metrics for Zoetis Inc. and Viatris Inc.
Research and Development Expenses Breakdown: Zoetis Inc. vs Xenon Pharmaceuticals Inc.
Research and Development Expenses Breakdown: Zoetis Inc. vs MorphoSys AG
Research and Development: Comparing Key Metrics for Zoetis Inc. and BioCryst Pharmaceuticals, Inc.
Research and Development Investment: argenx SE vs Blueprint Medicines Corporation
Who Prioritizes Innovation? R&D Spending Compared for Biogen Inc. and Blueprint Medicines Corporation
R&D Spending Showdown: BeiGene, Ltd. vs Blueprint Medicines Corporation
Neurocrine Biosciences, Inc. or Blueprint Medicines Corporation: Who Invests More in Innovation?
Research and Development Investment: Blueprint Medicines Corporation vs Ionis Pharmaceuticals, Inc.
Blueprint Medicines Corporation or Vericel Corporation: Who Invests More in Innovation?
Research and Development Expenses Breakdown: Blueprint Medicines Corporation vs Iovance Biotherapeutics, Inc.
Research and Development Expenses Breakdown: Blueprint Medicines Corporation vs MannKind Corporation